Palivizumab (Synagis) is indicated for the prevention of serious lower respiratory tract disease requiring hospitalization caused by respiratory syncytial virus
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
Minister was briefed on the nationwide dengue situation
‘Sanjeevani’ aims to raise awareness and encourage conversations around the silent cancer epidemic
Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)
30 beneficiaries avail of services per minute
India is promoting holistic healthcare with emphasis on preventive care
National Health Authority (NHA) to host the two-day Arogya Manthan event in New Delhi
Dr. Jitendra Singh inaugurates 300 LPM capacity Oxygen Plant, Day Care Chemotherapy Unit affiliated to Tata Memorial Hospital & Maternal ICU at GMC Kathua
The campus in Genome Valley will provide services in discovery chemistry & discovery biology, safety toxicology, bioanalytical services and formulation development to global pharmaceutical companies
Subscribe To Our Newsletter & Stay Updated
